Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.

Stroke. 2012 Jun;43(6):1511-7. doi: 10.1161/STROKEAHA.112.650614. Epub 2012 Apr 5.

2.

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.

Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.

Circulation. 2012 Feb 7;125(5):669-76. doi: 10.1161/CIRCULATIONAHA.111.055970. Epub 2012 Jan 3.

3.

Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation?

Lautz TB, Abbas F, Walsh SJ, Chow C, Amaranto DJ, Wang E, Blackburn D, Pearce WH, Kibbe MR.

Ann Surg. 2010 Apr;251(4):735-42. doi: 10.1097/SLA.0b013e3181c1ae95.

PMID:
19858700
5.

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators.

Circulation. 2012 Jul 17;126(3):343-8. doi: 10.1161/CIRCULATIONAHA.111.090464. Epub 2012 Jun 14. Erratum in: Circulation. 2012 Sep 4;126(10):e160. Heidbuchle, Hein [corrected to Heidbuchel, Hein].

6.

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S.

Lancet. 2006 Jun 10;367(9526):1903-12.

PMID:
16765759
7.

Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.

Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.

J Am Coll Cardiol. 2012 Mar 27;59(13):1168-74. doi: 10.1016/j.jacc.2011.12.014. Epub 2012 Feb 1.

8.

Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.

Mason PK, Lake DE, DiMarco JP, Ferguson JD, Mangrum JM, Bilchick K, Moorman LP, Moorman JR.

Am J Med. 2012 Jun;125(6):603.e1-6. doi: 10.1016/j.amjmed.2011.09.030. Epub 2012 Apr 11.

9.
10.

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data.

Heneghan C, Ward A, Perera R; Self-Monitoring Trialist Collaboration, Bankhead C, Fuller A, Stevens R, Bradford K, Tyndel S, Alonso-Coello P, Ansell J, Beyth R, Bernardo A, Christensen TD, Cromheecke ME, Edson RG, Fitzmaurice D, Gadisseur AP, Garcia-Alamino JM, Gardiner C, Hasenkam JM, Jacobson A, Kaatz S, Kamali F, Khan TI, Knight E, Körtke H, Levi M, Matchar D, Menéndez-Jándula B, Rakovac I, Schaefer C, Siebenhofer A, Souto JC, Sunderji R, Gin K, Shalansky K, Völler H, Wagner O, Zittermann A.

Lancet. 2012 Jan 28;379(9813):322-34. doi: 10.1016/S0140-6736(11)61294-4. Epub 2011 Nov 30. Review. Erratum in: Lancet. 2012 Mar 24;379(9821):1102.

12.

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.

Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, Baigent C.

Health Technol Assess. 2005 Dec;9(49):iii-iv, ix-x, 1-78. Review.

13.

Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients.

Sellers MB, Newby LK.

Am Heart J. 2011 Feb;161(2):241-6. doi: 10.1016/j.ahj.2010.11.002. Review.

PMID:
21315204
15.

Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry.

Hammerstingl C, Schmitz A, Fimmers R, Omran H.

Cardiovasc Ther. 2009 Winter;27(4):230-8. doi: 10.1111/j.1755-5922.2009.00099.x.

PMID:
19903186
16.

Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis.

Kennedy F, Lanfranconi S, Hicks C, Reid J, Gompertz P, Price C, Kerry S, Norris J, Markus HS; CADISS Investigators.

Neurology. 2012 Aug 14;79(7):686-9. doi: 10.1212/WNL.0b013e318264e36b. Epub 2012 Aug 1.

PMID:
22855862
17.

A new era for anticoagulation in atrial fibrillation.

Mega JL.

N Engl J Med. 2011 Sep 15;365(11):1052-4. doi: 10.1056/NEJMe1109748. Epub 2011 Aug 27. No abstract available.

PMID:
21870977
18.

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).

Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E.

Am Heart J. 2010 Oct;160(4):635-41. doi: 10.1016/j.ahj.2010.06.042.

PMID:
20934556
19.

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

Yasaka M, Sakata T, Naritomi H, Minematsu K.

Thromb Res. 2005;115(6):455-9.

PMID:
15792675
20.

Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.

Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC.

Clin Gastroenterol Hepatol. 2012 Jul;10(7):776-83. doi: 10.1016/j.cgh.2012.01.012. Epub 2012 Jan 28.

PMID:
22289875

Supplemental Content

Support Center